# EDGAR Filing Document

**Accession Number:** 0001877322
**File Stem:** 0001877322-25-000133
**Filing Date:** 2025-8
**Character Count:** 43502
**Document Hash:** a200f6a5ee0e3cf8ea807bcfbac7a72a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001877322-25-000133.hdr.sgml**: 20250806

**ACCESSION NUMBER**: 0001877322-25-000133

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250806

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250806

**DATE AS OF CHANGE**: 20250806

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ESAB Corp
- **CENTRAL INDEX KEY:** 0001877322
- **STANDARD INDUSTRIAL CLASSIFICATION:** GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 870923837
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41297
- **FILM NUMBER:** 251187321

**BUSINESS ADDRESS:**
- **STREET 1:** 909 ROSE AVENUE
- **STREET 2:** 8TH FLOOR
- **CITY:** NORTH BETHESDA
- **STATE:** MD
- **ZIP:** 20852
- **BUSINESS PHONE:** (302) 252-9160

**MAIL ADDRESS:**
- **STREET 1:** 909 ROSE AVENUE
- **STREET 2:** 8TH FLOOR
- **CITY:** NORTH BETHESDA
- **STATE:** MD
- **ZIP:** 20852

?xml version='1.0' encoding='ASCII'? esab-20250806

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): August 6, 2025

**ESAB Corporation**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41297** | **87-0923837** |
| (State or other jurisdiction | (Commission | (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |

---

**909 Rose Avenue, 8th Floor** 

**North Bethesda, MD 20852** 

(Address of Principal Executive Offices) (Zip Code)

**(301) 323-9099** 

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per share | ESAB | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02. Results of Operations and Financial Condition.**

On August 6, 2025, the Company issued a press release reporting financial results for the second quarter ended July 4, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into Item 2.02 of this report by reference. The Company has scheduled a conference call for 8:00 a.m. Eastern on August 6, 2025 to discuss its financial results.

The information furnished in this Current Report, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set for by specific reference in such filing.

------

**Item 9.01. Financial Statements and Exhibits.**

**(d)**&nbsp;&nbsp;&nbsp;&nbsp;**Exhibits**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[99.1 ESAB Corporation press release dated August 6, 2025, reporting financial results for the second quarter ended July 4, 2025](q22025earningspressrelease.htm)</u>

104 Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date: | August 6, 2025 |  | **ESAB Corporation** |
|  |  | By: | /s/ Renato Negro |
|  |  | Name: | Renato Negro |
|  |  | Title: | Controller and Chief Accounting Officer |
|  |  |  | (Principal Accounting Officer) |

---

## Exhibit 99.1

![esabcorplogo.jpg](esabcorplogo.jpg)

**ESAB Corporation Announces Second Quarter 2025 Results**

• Strong performance in high-growth markets

• Record Core adjusted EBITDA margin

• Two Gas Control acquisitions completed, and one Fab Tech acquisition signed

• Raised full year 2025 guidance

North Bethesda, MD, August 6, 2025 -- ESAB Corporation ("ESAB" or the "Company") (NYSE: ESAB), a focused premier industrial compounder, today announced financial results for the second quarter of 2025.

ESAB reported second quarter sales of $716 million, an increase of 1% on a reported basis or a decrease of 1% on a core organic growth basis before acquisitions and currency translation, as compared to the prior year. ESAB also reported second quarter net income from continuing operations attributable to ESAB of $69 million or $1.12 diluted earnings per share and core adjusted net income of $84 million or $1.36 diluted earnings per share. Core adjusted EBITDA of $138 million rose 3% and margin expanded 30 basis points to 20.4%, both as compared to the prior year quarter.

"ESAB delivered another quarter of record core adjusted EBITDA margins, reflecting the consistent performance of our team and the resilience of our global operating model," said Shyam P. Kambeyanda, President and CEO of ESAB Corporation. "Robust demand in EMEA and APAC enabled us to sustain momentum, while our Americas team navigated tariff-related pressures successfully using EBX."

Kambeyanda continued, "We also advanced our compounder strategy with two strategic acquisitions: DeltaP and Aktiv, which expand our medical gas control business; and signed EWM, a European leader in heavy industrial and robotic welding equipment, which enhances our Fabtech portfolio. These acquisitions, a sequentially improving Americas, combined with our strong positioning in high-growth markets and our continued focus on EBX gives us confidence to raise our full-year guidance."

**<u>Full Year 2025 Outlook</u>**

ESAB raises its full year 2025 outlook for total core sales growth of 1.5% to 3.5%, core organic sales growth of 0.0% to 2.0%, M&A of ~2.5% and FX of ~(1.0)% from its prior outlook of total core sales growth of (1.0)% to 1.5%, core organic sales growth of 0.0% to 2.0%, M&A of 2.0%-2.5% and FX of ~(3.0)%. ESAB's core adjusted EBITDA outlook increases to $525 to $535 million versus prior guidance of $520 to $530 million, and core adjusted EPS increases to $5.15 to $5.30 versus prior guidance of $5.10 to $5.25.

**<u>About ESAB Corporation</u>**

Founded in 1904, ESAB Corporation is a focused industrial compounder. The Company's rich history of innovative products, workflow solutions and its business system ESAB Business Excellence ("EBX"), enables the Company's purpose of *Shaping the world we imagine*<sup>TM</sup>. ESAB Corporation is based in North Bethesda, Maryland and employs approximately 9,300 associates and serves customers in approximately 150 countries. To learn more, visit <u>www.ESABcorporation.com.</u>

**<u>About About EWM GmbH</u>**

Founded in 1957, EWM GmbH ("EWM") is Germany's leading provider of premium arc welding technology solutions. The Westerwald-based company offers complete systems including high-quality welding machines, components, torches, consumables and accessories for manual and automated applications. EWM has a global presence with more than 400 sales and service partners and a high degree of vertical integration through 6 production locations worldwide. The company has a track-record of innovation and has around 800 employees at 12 German and 11 international locations.

**<u>About Aktiv Technologies and DeltaP</u>**

Aktiv Technologies Private Limited is a gas equipment manufacturer based in India. DeltaP is a European provider of comprehensive medical central gas systems and aftermarket services.

------

**<u>Conference Call and Webcast</u>**

The Company will hold a conference call to discuss its second quarter 2025 results beginning at 8:00 a.m. Eastern on Wednesday, August 6, 2025, which will be open to the public by calling +1-888-550-5302 (U.S. callers) and +1-646-960-0685 (International callers) and referencing the conference ID number 4669992 and through webcast via ESAB's website <u>www.ESABcorporation.com</u> under the "Investors" section. Access to a supplemental slide presentation can also be found on ESAB's website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call. The Company's quarterly report on Form 10-Q for the fiscal quarter ended July 4, 2025, filed August 6, 2025, is also available on ESAB's website under the "Investors" section.

**<u>Non-GAAP Financial Measures and Other Adjustments</u>**

ESAB has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the United States ("non-GAAP"). ESAB presents some of these non-GAAP financial measures including and excluding Russia due to economic and political volatility caused by the war in Ukraine, which results in enhanced investor interest in this information. Core non-GAAP financial measures exclude Russia for the three and six months ended July 4, 2025 and June 28, 2024. These non-GAAP financial measures may include one or more of the following: adjusted net income from continuing operations, Core adjusted net income from continuing operations, adjusted EBITDA (earnings before interest, taxes, Pension settlement loss, Restructuring and other related charges, acquisition due diligence and transaction expenses, amortization of intangibles and fair value charges on acquired inventories and depreciation and other amortization), Core adjusted EBITDA, organic sales, Core organic sales, adjusted free cash flow and ratios based on the foregoing measures. ESAB also provides adjusted EBITDA and adjusted EBITDA margin on a segment basis, as well as Core adjusted EBITDA and Core adjusted EBITDA margin on a segment basis.

Adjusted net income from continuing operations represents Net income from continuing operations attributable to ESAB Corporation, excluding Restructuring and other related charges, acquisition due diligence and transaction expenses, amortization of intangibles and fair value charges on acquired inventories and Pension settlement loss. Adjusted net income, includes the tax effect of non-GAAP adjusting items at applicable tax rates and excludes the impact of discrete tax charges or gains in each period. ESAB also presents adjusted net income margin from continuing operations, which is subject to the same adjustments as adjusted net income from continuing operations. Adjusted net income per diluted share from continuing operations is a calculation of adjusted net income from continuing operations over the weighted-average diluted shares outstanding. ESAB also presents Core adjusted net income from continuing operations and Core adjusted net income per share - diluted from continuing operations, which are subject to the same adjustments as Adjusted net income from continuing operations and Adjusted net income per diluted share from continuing operations, further removing the impact of Russia for the three and six months ended July 4, 2025 and June 28, 2024.

Adjusted EBITDA excludes from Net income from continuing operations the effect of Income tax expense, Interest expense and other, net, Restructuring and other related charges, acquisition due diligence and transaction expenses, amortization of intangibles and fair value charges on acquired inventories, Pension settlement loss and depreciation and other amortization. ESAB presents adjusted EBITDA margin, which are subject to the same adjustments as adjusted EBITDA. Further, ESAB presents these non-GAAP performance measures on a segment basis, which excludes the impact of Restructuring and other related charges, acquisition due diligence and transaction expenses, amortization of intangibles and fair value charges on acquired inventories, Pension settlement loss and depreciation and other amortization from operating income. ESAB also presents Core adjusted EBITDA and Core adjusted EBITDA margin, which are subject to the same adjustments as Adjusted EBITDA and Adjusted EBITDA margin, respectively, further removing the impact of Russia for the three and six months ended July 4, 2025 and June 28, 2024.

ESAB presents organic sales, which excludes the impact of acquisitions and foreign exchange rate fluctuations and presents core organic sales, which further excludes the impact of the Russia business for the three and six months ended July 4, 2025 and June 28, 2024.

Adjusted free cash flow represents cash flows from operating activities excluding cash outflows related to discontinued operations and acquisition-related payments less Purchases of property, plant and equipment.

These non-GAAP financial measures assist ESAB management in comparing its operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to unusual events or discrete restructuring plans and other initiatives that are fundamentally different from the ongoing productivity and core business of the Company.

------

ESAB management also believes that presenting these measures allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.

***<u>Forward Looking Statements</u>***

*This press release includes forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning the Company's plans, goals, objectives, outlook, expectations, and intentions, and other statements that are not historical or current fact. Forward-looking statements are based on the Company's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements, including general risks and uncertainties such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns, natural disasters or other disruptions of expected business conditions. Factors that could cause the Company's results to differ materially from current expectations include, but are not limited to, risks related to the impact of the wars in Ukraine and Middle East and the resulting escalating geopolitical tensions; impact of supply chain disruptions; the impact of creditworthiness and financial viability of customers; impact of inflationary pressures, tariffs and trade policies, foreign exchange fluctuations and commodity prices; other impacts on the Company's business and ability to execute business continuity plans; and the other factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission ("SEC") on February 20, 2025, and the Form 10-Q for the quarterly period ended April 4, 2025 filed with the SEC on May 1, 2025, as well as other risks discussed in the Company's filings with the SEC. In addition, these statements are based on assumptions that are subject to change. This press release speaks only as of the date hereof. The Company disclaims any duty to update the information herein.*

**<u>Investor Relations Contact:</u>**

Mark Barbalato

Vice President, Investor Relations

E-mail: investorrelations@esab.com

Phone: 1-301-323-9098

**<u>Media Contact:</u>**

Tilea Coleman

Vice President, Corporate Communications

E-mail: mediarelations@esab.com

Phone: 1-301-323-9092

------

**ESAB CORPORATION**

**CONSOLIDATED AND CONDENSED STATEMENTS OF OPERATIONS**

**Dollars in thousands, except per share data**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **July 4, 2025** | **June 28, 2024** | **July 4, 2025** | **June 28, 2024** |
| Net sales | $715586 | $707053 | $1393724 | $1396797 |
| Cost of sales | 449539 | 436738 | 872475 | 871455 |
| Gross profit | 266047 | 270315 | 521249 | 525342 |
| Selling, general and administrative expense | 155563 | 146187 | 296421 | 288637 |
| Restructuring and other related charges | 1390 | 4773 | 5889 | 6697 |
| Operating income | 109094 | 119355 | 218939 | 230008 |
| Pension settlement loss |  |  |  | 12155 |
| Interest expense and other, net | 20999 | 15940 | 37781 | 33031 |
| Income from continuing operations before income taxes | 88095 | 103415 | 181158 | 184822 |
| Income tax expense | 18283 | 17885 | 38782 | 36389 |
| Net income from continuing operations | 69812 | 85530 | 142376 | 148433 |
| Loss from discontinued operations, net of taxes | (1708) | (1161) | (4440) | (2470) |
| Net income | 68104 | 84369 | 137936 | 145963 |
| Income attributable to noncontrolling interest, net of taxes | (1221) | (1462) | (3690) | (3105) |
| Net income attributable to ESAB Corporation | $66883 | $82907 | $134246 | $142858 |
| *Earnings (loss) per share – basic* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations | $1.13 | $1.38 | $2.28 | $2.39 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on discontinued operations | (0.03) | (0.02) | $(0.07) | $(0.04) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per share – basic | $1.10 | $1.36 | $2.21 | $2.35 |
| *Earnings (loss) per share – diluted* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations | $1.12 | $1.37 | $2.26 | $2.37 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on discontinued operations | (0.03) | (0.02) | $(0.07) | $(0.04) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per share – diluted | $1.09 | $1.35 | $2.19 | $2.33 |

---

------

**ESAB CORPORATION**

**RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES**

**Dollars in millions, except per share data**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended**<sup>(1)</sup> | **Three Months Ended**<sup>(1)</sup> | **Six Months Ended**<sup>(1)</sup> | **Six Months Ended**<sup>(1)</sup> |
| | **July 4, 2025** | **June 28, 2024** | **July 4, 2025** | **June 28, 2024** |
| **Adjusted Net Income** | | | | |
| Net income from continuing operations (GAAP) | $69.8 | $85.5 | $142.4 | $148.4 |
| Less: Income attributable to noncontrolling interest, net of taxes | 1.2 | 1.5 | 3.7 | 3.1 |
| Net income from continuing operations attributable to ESAB Corporation (GAAP) | 68.6 | 84.0 | 138.7 | 145.3 |
| Restructuring and other related charges – pretax<sup>(2)</sup> | 1.4 | 4.8 | 5.9 | 6.7 |
| Acquisition-amortization and other related charges – pretax<sup>(3)</sup> | 21.6 | 7.7 | 31.2 | 15.5 |
| Pension settlement loss – pretax |  |  |  | 12.2 |
| Tax effect on above items<sup>(4)</sup> | (5.3) | (3.2) | (8.8) | (8.5) |
| Discrete tax adjustments<sup>(5)</sup> |  | (6.7) |  | (6.7) |
| Adjusted net income from continuing operations (non-GAAP) | 86.2 | 86.6 | 166.9 | 164.5 |
| Adjusted net income from continuing operations attributable to Russia (non-GAAP)<sup>(6)</sup> | 2.3 | 5.2 | 6.0 | 9.5 |
| Core adjusted net income from continuing operations (non-GAAP) | $84.0 | $81.4 | $160.9 | $155.0 |
| Adjusted net income margin from continuing operations | 12.0% | 12.3% | 12.0% | 11.8% |
| **Adjusted Net Income Per Share** |  |  |  |  |
| Net income per share – diluted from continuing operations (GAAP) | $1.12 | $1.37 | $2.26 | $2.37 |
| Restructuring and other related charges – pretax<sup>(2)</sup> | 0.02 | 0.08 | 0.10 | 0.11 |
| Acquisition-amortization and other related charges – pretax<sup>(3)</sup> | 0.35 | 0.12 | 0.51 | 0.24 |
| Pension settlement loss – pretax |  |  |  | 0.20 |
| Tax effect on above items<sup>(4)</sup> | (0.09) | (0.05) | (0.14) | (0.14) |
| Discrete tax adjustments<sup>(5)</sup> |  | (0.11) |  | (0.11) |
| Adjusted net income per share – diluted from continuing operations (non-GAAP) | 1.40 | 1.41 | 2.72 | 2.67 |
| Adjusted net income per share – diluted from continuing operations attributable to Russia (non-GAAP)<sup>(6)</sup> | 0.04 | 0.09 | 0.10 | 0.16 |
| Core adjusted net income per share – diluted from continuing operations (non-GAAP) | $1.36 | $1.32 | $2.62 | $2.51 |

---

<sup>__________</sup><sup>(1)</sup> Numbers may not sum due to rounding.

<sup>(2)</sup> Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.

<sup>(3)</sup> Includes transaction, diligence and integration expenses totaling $12.8 million and $14.2 million for the three and six months ended July 4, 2025, respectively, and $0.5 million and $0.6 million for the three and six months ended June 28, 2024, respectively. Additionally, it includes amortization of intangibles and fair value charges on acquired inventories totaling $8.8 million and $17.0 million three and six months ended July 4, 2025, respectively, and $7.3 million and $14.9 million for the three and six months ended June 28, 2024, respectively.

<sup>(4)</sup> This line item reflects the aggregate tax effect of all non-tax adjustments reflected in the proceeding line items of the table. ESAB estimates the tax effect of each adjustment item by applying ESAB's overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment.

<sup>(5)</sup> For 2024, discrete adjustments relate to a favorable final ruling in a tax case in a foreign jurisdiction.

<sup>(6)</sup> Represents Russia contribution for the three and six months ended July 4, 2025 and June 28, 2024.

------

**ESAB CORPORATION**

**RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES**

**Dollars in millions**

**(Unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended July 4, 2025**<sup>(1)</sup> | **Three Months Ended July 4, 2025**<sup>(1)</sup> | **Three Months Ended July 4, 2025**<sup>(1)</sup> | **Six Months Ended July 4, 2025**<sup>(1)</sup> | **Six Months Ended July 4, 2025**<sup>(1)</sup> | **Six Months Ended July 4, 2025**<sup>(1)</sup> |
| | **Americas** | **EMEA & APAC** | **Total** | **Americas** | **EMEA & APAC** | **Total** |
| Net income from continuing operations (GAAP) |  |  | $69.8 |  |  | $142.4 |
| &nbsp;&nbsp;&nbsp;Income tax expense |  |  | 18.3 |  |  | 38.8 |
| &nbsp;&nbsp;&nbsp;Interest expense and other, net |  |  | 21.0 |  |  | 37.8 |
| Operating income (GAAP) | $42.4 | $66.7 | $109.1 | 85.7 | 133.3 | 218.9 |
| Adjusted to add |  |  |  |  |  |  |
| &nbsp;&nbsp;Restructuring and other related charges<sup>(2)</sup> | 0.5 | 0.9 | 1.4 | 2.2 | 3.7 | 5.9 |
| &nbsp;&nbsp;Acquisition-amortization and other related charges<sup>(3)</sup> | 10.0 | 11.5 | 21.6 | 15.7 | 15.5 | 31.2 |
| &nbsp;&nbsp;&nbsp;Depreciation and other amortization | 3.8 | 7.6 | 11.4 | 7.7 | 13.6 | 21.4 |
| Adjusted EBITDA (non-GAAP) | 56.8 | 86.7 | 143.5 | $111.3 | $166.1 | $277.4 |
| &nbsp;&nbsp;Adjusted EBITDA attributable to Russia (non-GAAP)<sup>(4)</sup> |  | 5.0 | 5.0 |  | 11.0 | 11.0 |
| Core adjusted EBITDA (non-GAAP) | $56.8 | $81.7 | $138.5 | $111.3 | $155.1 | $266.4 |
| Adjusted EBITDA margin (non-GAAP) | 20.1% | 20.0% | 20.1% | 19.8% | 20.0% | 19.9% |
| Core adjusted EBITDA margin (non-GAAP)<sup>(5)</sup> | 20.1% | 20.6% | 20.4% | 19.8% | 20.4% | 20.1% |

---

<sup>__________</sup>

<sup>(1)</sup> Numbers may not sum due to rounding.

<sup>(2)</sup> Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.

<sup>(3)</sup> Includes transaction, diligence and integration expenses totaling $12.8 million and $14.2 million for the three and six months ended July 4, 2025, respectively, and amortization of intangibles and fair value charges on acquired inventories totaling $8.8 million and $17.0 million three and six months ended July 4, 2025, respectively.

<sup>(4)</sup> Numbers calculated following the same definition as Adjusted EBITDA for total Company.

<sup>(5)</sup> Net sales were $37.1 million and $68.4 million relating to Russia for the three and six months ended July 4, 2025, respectively.

------

**ESAB CORPORATION**

**RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES**

**Dollars in millions**

**(Unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 28, 2024**<sup>(1)</sup> | **Three Months Ended June 28, 2024**<sup>(1)</sup> | **Three Months Ended June 28, 2024**<sup>(1)</sup> | **Six Months Ended June 28, 2024**<sup>(1)</sup> | **Six Months Ended June 28, 2024**<sup>(1)</sup> | **Six Months Ended June 28, 2024**<sup>(1)</sup> |
| | **Americas** | **EMEA & APAC** | **Total** | **Americas** | **EMEA & APAC** | **Total** |
| Net income from continuing operations (GAAP) |  |  | $85.5 |  |  | $148.4 |
| &nbsp;&nbsp;&nbsp;Income tax expense |  |  | 17.9 |  |  | 36.4 |
| &nbsp;&nbsp;&nbsp;Interest expense and other, net |  |  | 15.9 |  |  | 33.0 |
| &nbsp;&nbsp;&nbsp;Pension settlement loss |  |  |  |  |  | 12.2 |
| Operating income (GAAP) | $55.9 | $63.4 | $119.4 | $101.9 | $128.1 | $230.0 |
| Adjusted to add |  |  |  |  |  |  |
| &nbsp;&nbsp;Restructuring and other related charges<sup>(2)</sup> | 0.8 | 4.0 | 4.8 | 1.1 | 5.6 | 6.7 |
| &nbsp;&nbsp;Acquisition-amortization and other related charges<sup>(3)</sup> | 4.3 | 3.3 | 7.7 | 8.7 | 6.8 | 15.5 |
| &nbsp;&nbsp;&nbsp;Depreciation and other amortization | 3.7 | 5.5 | 9.1 | 7.2 | 10.7 | 17.9 |
| Adjusted EBITDA (non-GAAP) | 64.7 | 76.3 | 141.0 | 118.8 | 151.2 | 270.1 |
| &nbsp;&nbsp;Adjusted EBITDA attributable to Russia (non-GAAP)<sup>(4)</sup> |  | 6.9 | 6.9 |  | 12.9 | 12.9 |
| Core adjusted EBITDA (non-GAAP) | $64.7 | $69.3 | $134.0 | $118.8 | $138.3 | $257.3 |
| Adjusted EBITDA margin (non-GAAP) | 20.9% | 19.2% | 19.9% | 19.6% | 19.1% | 19.3% |
| Core adjusted EBITDA margin (non-GAAP)<sup>(5)</sup> | 20.9% | 19.5% | 20.1% | 19.6% | 19.3% | 19.5% |

---

 

<sup>(1)</sup> Numbers may not sum due to rounding.

<sup>(2)</sup> Includes severance and other termination benefits, including outplacement services as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines.

<sup>(3)</sup> Includes transaction, diligence and integration expenses totaling $0.5 million and $0.6 million for the three and six months ended June 28, 2024, respectively, and amortization of intangibles and fair value charges on acquired inventories totaling $7.3 million and $14.9 million for the three and six months ended June 28, 2024, respectively.

<sup>(4)</sup> Numbers calculated following the same definition as Adjusted EBITDA for total Company.

<sup>(5)</sup> Net sales were $40.7 million and $74.4 million relating to Russia for the three and six months ended June 28, 2024, respectively.

------

**ESAB CORPORATION**

**RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES**

**Change in Sales**

**Dollars in millions**

**(Unaudited)**

---

| | | | |
|:---|:---|:---|:---|
| | **Sales**<sup>(1)</sup> | **Sales**<sup>(1)</sup> | **Sales**<sup>(1)</sup> |
| | **Americas** | **EMEA & APAC** | **Total ESAB** |
| | $**Change %** | $**Change %** | $**Change %** |
| For the three months ended June 28, 2024 |  |  |  |
| &nbsp;&nbsp;&nbsp;*Components of Change:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Existing businesses (organic sales)<sup>(2)</sup> | (7.2)% | 1.7% | (2.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions<sup>(3)</sup> | 2.6% | 3.2% | 3.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign Currency translation<sup>(4)</sup> | (4.2)% | 4.1% | 0.5% |
| &nbsp;&nbsp;&nbsp;Total sales (decline) growth | (8.7)% | 9.0% | 1.2% |
| For the three months ended July 4, 2025 |  |  |  |

---

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Numbers may not sum due to rounding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup> Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(3)</sup> Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(4)</sup> Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.

---

| | | | |
|:---|:---|:---|:---|
| | **Core Sales**<sup>(1)(5)</sup> | **Core Sales**<sup>(1)(5)</sup> | **Core Sales**<sup>(1)(5)</sup> |
| | **Americas** | **EMEA & APAC** | **ESAB** |
| | $**Change %** | $**Change %** | $**Change %** |
| For the three months ended June 28, 2024 |  |  |  |
| &nbsp;&nbsp;&nbsp;*Components of Change:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Existing businesses (core organic sales)<sup>(2)</sup> | (7.2)% | 4.4% | (1.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions<sup>(3)</sup> | 2.6% | 3.6% | 3.1% |
| &nbsp;&nbsp;Foreign Currency translation<sup>(4)</sup> | (4.2)% | 3.1% | (0.3)% |
| Total core sales (decline) growth | (8.7)% | 11.0% | 1.8% |
| For the three months ended July 4, 2025 |  |  |  |

---

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Numbers may not sum due to rounding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup> Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(3)</sup> Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(4)</sup> Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(5)</sup> Represents sales excluding Russia for the three months ended July 4, 2025 and June 28, 2024.

------

**ESAB CORPORATION**

**RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES**

**Change in Sales**

**Dollars in millions**

**(Unaudited)**

---

| | | | |
|:---|:---|:---|:---|
| | **Sales Growth**<sup>(1)</sup> | **Sales Growth**<sup>(1)</sup> | **Sales Growth**<sup>(1)</sup> |
| | **Americas** | **EMEA & APAC** | **Total ESAB** |
| | $**Change %** | $**Change %** | $**Change %** |
| For the six months ended June 28, 2024 |  |  |  |
| &nbsp;&nbsp;&nbsp;*Components of Change:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Existing businesses (organic sales)<sup>(2)</sup> | (4.9)% | 1.6% | (1.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions<sup>(3)</sup> | 2.9% | 2.3% | 2.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign Currency translation<sup>(4)</sup> | (5.1)% | 1.1% | (1.6)% |
| &nbsp;&nbsp;&nbsp;Total sales (decline) growth | (7.0)% | 5.0% | (0.2)% |
| For the six months ended July 4, 2025 |  |  |  |

---

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Numbers may not sum due to rounding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup> Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(3)</sup> Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(4)</sup> Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.

---

| | | | |
|:---|:---|:---|:---|
| | **Core Sales Growth**<sup>(1)(5)</sup> | **Core Sales Growth**<sup>(1)(5)</sup> | **Core Sales Growth**<sup>(1)(5)</sup> |
| | **Americas** | **EMEA & APAC** | **ESAB** |
| | $**Change %** | $**Change %** | $**Change %** |
| For the six months ended June 28, 2024 |  |  |  |
| &nbsp;&nbsp;&nbsp;*Components of Change:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Existing businesses (core organic sales)<sup>(2)</sup> | (4.9)% | 3.3% | (0.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions<sup>(3)</sup> | 2.9% | 2.5% | 2.7% |
| &nbsp;&nbsp;Foreign Currency translation<sup>(4)</sup> | (5.1)% | 0.5% | (2.1)% |
| Total core sales (decline) growth | (7.0)% | 6.3% | 0.2% |
| For the six months ended July 4, 2025 |  |  |  |

---

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Numbers may not sum due to rounding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup> Excludes the impact of acquisitions and foreign exchange rate fluctuations, thus providing a measure of change due to organic growth factors such as price, product mix and volume.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(3)</sup> Represents the incremental sales in comparison to the portion of the prior period during which we did not own the business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(4)</sup> Represents the difference between prior year sales valued at the actual prior year foreign exchange rates and prior year sales valued at current year foreign exchange rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(5)</sup> Represents sales excluding Russia for the six months ended July 4, 2025 and June 28, 2024.

------

**ESAB CORPORATION**

**RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES**

**Adjusted Free Cash Flow**

**Dollars in millions**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **July 4, 2025** | **June 28, 2024** | **July 4, 2025** | **June 28, 2024** |
| Net cash provided by operating activities (GAAP) | $46.6 | $83.0 | $82.0 | $127.5 |
| Purchases of property, plant and equipment (GAAP) | (9.2) | (9.0) | (16.5) | (16.4) |
| Payments related to discontinued operations | 4.9 | 4.8 | 7.2 | 8.5 |
| Acquisition-related payments<sup>(1)</sup> | 4.0 |  | 4.0 |  |
| Adjusted free cash flow (non-GAAP)<sup>(2)</sup> | $46.4 | $78.8 | $76.8 | $119.5 |

---

 

<sup>(1)</sup> Represents payments related to due diligence, transaction and other related costs.

<sup>(2)</sup> Numbers may not sum due to rounding.

------

**ESAB CORPORATION**

**2025 Outlook**

**Dollars in millions, except per share amounts**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| **ESAB 2025 Outlook** | **ESAB 2025 Outlook** | **ESAB 2025 Outlook** |
| | **Previous Guidance** | **New Guidance** |
| **2024 Core net sales** | $**2591.2** | $**2591.2** |
| &nbsp;&nbsp;&nbsp;Organic growth | 0.0%-2.0% | 0.0%-2.0% |
| &nbsp;&nbsp;Acquisitions  | 2.0%-2.5% | ~2.5% |
| &nbsp;&nbsp;Currency | ~(3.0)% | ~(1.0)% |
| **2025 Core net sales growth range** | **(1.0)%-1.5%** | **1.5%-3.5%** |
| **2024 Core adjusted EBITDA** | $**510.7** | $**510.7** |
| **2025 Core adjusted EBITDA range** | **$520 - $530** | **$525 - $535** |
| **2024 Core adjusted EPS** | $**5.06** | $**5.06** |
| **2025 Core adjusted EPS range** | **$5.10 - $5.25** | **$5.15 - $5.30** |

---

------

**ESAB CORPORATION**

**CONSOLIDATED AND CONDENSED BALANCE SHEETS**

**Dollars in thousands, except share and per share amounts**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **July 4, 2025** | **December 31, 2024** |
| **ASSETS** | | |
| &nbsp;&nbsp;&nbsp;CURRENT ASSETS: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $258223 | $249358 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade receivables, less allowance for credit losses of $23,711 and $23,850 | 456112 | 370321 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 474095 | 403711 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 67226 | 55665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 80624 | 69327 |
| &nbsp;&nbsp;&nbsp;Total current assets | 1336280 | 1148382 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | 326685 | 298347 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 1790053 | 1651993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 541973 | 487993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease assets - right of use | 88763 | 89859 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 348609 | 357401 |
| Total assets | $4432363 | $4033975 |
| **LIABILITIES AND EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;CURRENT LIABILITIES: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of debt | $21745 | $15000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 369520 | 318493 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 295204 | 298558 |
| &nbsp;&nbsp;&nbsp;Total current liabilities | 686469 | 632051 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | 1058832 | 1060739 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 575291 | 532936 |
| Total liabilities | 2320592 | 2225726 |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock - $0.001 par value - Authorized 600,000,000, 60,696,786 and 60,517,574 shares outstanding as of July 4, 2025 and December 31, 2024, respectively&nbsp;&nbsp;&nbsp;&nbsp; | 61 | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1898801 | 1901337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 720467 | 597180 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (549699) | (729574) |
| Total ESAB Corporation equity | 2069630 | 1769004 |
| Noncontrolling interest | 42141 | 39245 |
| Total equity | 2111771 | 1808249 |
| Total liabilities and equity | $4432363 | $4033975 |

---

------

**ESAB CORPORATION**

**CONSOLIDATED AND CONDENSED STATEMENTS OF CASH FLOWS**

**Dollars in thousands**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **July 4, 2025** | **June 28, 2024** |
| **Cash flows from operating activities:** | | |
| &nbsp;&nbsp;&nbsp;Net income | $137936 | $145963 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization and other impairment charges | 36846 | 32930 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sale of property, plant and equipment | (5703) | 63 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 9900 | 9886 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax (benefit) expense | (6761) | 1760 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash interest expense | 1255 | 1632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension settlement loss |  | 12155 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade receivables, net | (49161) | (56680) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | (37407) | (42144) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 23183 | 53574 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating assets and liabilities | (28051) | (31656) |
| **Net cash provided by operating activities** | 82037 | 127483 |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (16474) | (16437) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant and equipment | 4732 | 608 |
| &nbsp;&nbsp;&nbsp;Acquisitions, net of cash received | (86252) | (18050) |
| &nbsp;&nbsp;&nbsp;Other investing | (500) | (3059) |
| **Net cash used in investing activities** | (98494) | (36938) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from borrowings on Senior Notes |  | 700000 |
| &nbsp;&nbsp;&nbsp;Proceeds from borrowings on revolving credit facilities and other | 8674 | 205000 |
| &nbsp;&nbsp;&nbsp;Repayments of borrowings on Term Loans | (5000) | (597500) |
| &nbsp;&nbsp;&nbsp;Repayments of borrowings on revolving credit facilities and other |  | (237005) |
| &nbsp;&nbsp;&nbsp;Payment of debt issuance costs |  | (10423) |
| &nbsp;&nbsp;&nbsp;Payment of dividends | (9729) | (7278) |
| &nbsp;&nbsp;&nbsp;Distributions to noncontrolling interest holders | (1174) | (1218) |
| &nbsp;&nbsp;&nbsp;Other financing | (12418) | (5295) |
| **Net cash (used in) provided by financing activities** | (19647) | 46281 |
| Effect of foreign exchange rates on Cash and cash equivalents | 44969 | (10359) |
| **Increase in Cash and cash equivalents** | 8865 | 126467 |
| Cash and cash equivalents, beginning of period | 249358 | 102003 |
| **Cash and cash equivalents, end of period** | $258223 | $228470 |

---